Skip to content

Fetal RHD screening in clinical routine

This paper by Dr. Agneta Wikman, Professor at Karolinska University Hospital explores an approach that uses non-invasive prenatal testing to determine the fetal RHD status, allowing targeted administration of antenatal anti-D prophylaxis only to those who will benefit from it. Learn more about the current strategies of fetal RHD and the experiences and considerations surrounding planning a fetal RHD screening program.

  • Current strategies of fetal RHD screening.
  • Requirements in clinical routine testing.
  • Planning a fetal RHD screening program.

Get access to the paper by filling out the form below

Fetal RHD screening in clinical routine

This paper by Dr. Agneta Wikman, Professor at Karolinska University Hospital explores an approach that uses non-invasive prenatal testing to determine the fetal RHD status, allowing targeted administration of antenatal anti-D prophylaxis only to those who will benefit from it. Learn more about the current strategies of fetal RHD and the experiences and considerations surrounding planning a fetal RHD screening program.

  • Current strategies of fetal RHD screening.
  • Requirements in clinical routine testing.
  • Planning a fetal RHD screening program.